Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

The endometrium is made up of cells that line the inside of the uterus and the production of abnormal cells in the ...

Menstrual disorders, causes, and management explained by obstetric-gynaecologists at Naruvi Hospitals, Vellore for women's ...

Dr Fuh, welcome to the Medscape InDiscussion: Endometrial Cancer podcast ... Let's say 5 years, 8 years down the line, is it still going to be HER2-expressing, or is something going to happen?

GSK has claimed US approval for Jemperli alongside chemotherapy for previously untreated, primary advanced or recurrent endometrial cancer, becoming the first immunotherapy option for first-line ...

Jemperli was the first drug in the class to be approved for front-line use in endometrial cancer last year, based on progression-free survival data from RUBY, but with a restricted label that ...

Acrivon Therapeutics Inc. provided updated phase II data for checkpoint kinase candidate ACR-368, highlighting promising response rates for biomarker-positive patients with endometrial cancer and ...